Cervical Adenocarcinoma
57
5
12
32
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
24 trials with published results (42%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
10.5%
6 terminated out of 57 trials
84.2%
-2.3% vs benchmark
12%
7 trials in Phase 3/4
75%
24 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 32 completed trials
Clinical Trials (57)
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
Effect of Prehabilitation on Recovery Outcomes in Post-Surgical Cervical Cancer Women
Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
RT for Adenocarcinoma/Adenosquamous Carcinoma
QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma
Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer